Isolation and sequencing of cDNAs for splice variants of growth hormone-releasing hormone receptors from human cancers.
about
Expression of a splice variant of the receptor for GHRH in 3T3 fibroblasts activates cell proliferation responses to GHRH analogsLigand-dependent and -independent effects of splice variant 1 of growth hormone-releasing hormone receptorAcceleration of wound healing by growth hormone-releasing hormone and its agonists.Human renal cell carcinoma expresses distinct binding sites for growth hormone-releasing hormone.A soluble mouse brain splice variant of type 2alpha corticotropin-releasing factor (CRF) receptor binds ligands and modulates their activityProtective effect of Growth Hormone-Releasing Hormone agonist in bacterial toxin-induced pulmonary barrier dysfunction.Effective treatment of experimental human non-Hodgkin's lymphomas with antagonists of growth hormone-releasing hormoneAntagonist of growth hormone-releasing hormone induces apoptosis in LNCaP human prostate cancer cells through a Ca2+-dependent pathway.Antagonists of growth hormone-releasing hormone cross the blood-brain barrier: a potential applicability to treatment of brain tumors.Antiproliferative effect of growth hormone-releasing hormone (GHRH) antagonist on ovarian cancer cells through the EGFR-Akt pathway.Agonist of growth hormone-releasing hormone as a potential effector for survival and proliferation of pancreatic isletsThe expression of growth hormone-releasing hormone (GHRH) and splice variants of its receptor in human gastroenteropancreatic carcinomas.The expression of the pituitary growth hormone-releasing hormone receptor and its splice variants in normal and neoplastic human tissuesGrowth hormone-releasing hormone (GHRH) antagonists inhibit the proliferation of androgen-dependent and -independent prostate cancers.Antagonists of growth hormone-releasing hormone (GHRH) reduce prostate size in experimental benign prostatic hyperplasiaAntagonistic analogs of growth hormone-releasing hormone increase the efficacy of treatment of triple negative breast cancer in nude mice with doxorubicin; A preclinical studyInhibition of mutant p53 expression and growth of DMS-153 small cell lung carcinoma by antagonists of growth hormone-releasing hormone and bombesin.Triple negative breast cancers express receptors for LHRH and are potential therapeutic targets for cytotoxic LHRH-analogs, AEZS 108 and AEZS 125Synergistic inhibition of growth of lung carcinomas by antagonists of growth hormone-releasing hormone in combination with docetaxelGrowth hormone-releasing hormone and extra-pituitary tumorigenesis: therapeutic and diagnostic applications of growth hormone-releasing hormone antagonists.Somatostatin receptor biology in neuroendocrine and pituitary tumours: part 1--molecular pathways.Potentiation of mammary cancer inhibition by combination of antagonists of growth hormone-releasing hormone with docetaxel.Stimulation of proliferation of MCF-7 breast cancer cells by a transfected splice variant of growth hormone-releasing hormone receptor.Antagonists of growth hormone-releasing hormone inhibit growth of androgen-independent prostate cancer through inactivation of ERK and Akt kinasesAgonist of growth hormone-releasing hormone reduces pneumolysin-induced pulmonary permeability edema.Improvement of islet function in a bioartificial pancreas by enhanced oxygen supply and growth hormone releasing hormone agonist.Increased activity of antagonists of growth hormone-releasing hormone substituted at positions 8, 9, and 10.Knocking down gene expression for growth hormone-releasing hormone inhibits proliferation of human cancer cell lines.New therapies for relapsed castration-resistant prostate cancer based on peptide analogs of hypothalamic hormones.Antagonists of growth hormone-releasing hormone suppress in vivo tumor growth and gene expression in triple negative breast cancersGrowth hormone-releasing hormone as an agonist of the ghrelin receptor GHS-R1aAntioxidant activity of growth hormone-releasing hormone antagonists in LNCaP human prostate cancer line.Mini-review: novel therapeutic strategies to blunt actions of pneumolysin in the lungsAlternative splicing of pre-mRNA in cancer: focus on G protein-coupled peptide hormone receptors.Expression of neuropeptide hormone receptors in human adrenal tumors and cell lines: antiproliferative effects of peptide analogues.Preclinical efficacy of growth hormone-releasing hormone antagonists for androgen-dependent and castration-resistant human prostate cancer.Development of a polyclonal antiserum for the detection of the isoforms of the receptors for human growth hormone-releasing hormone on tumors.Truncated somatostatin receptors as new players in somatostatin-cortistatin pathophysiology.Agonistic analogs of growth hormone releasing hormone (GHRH) promote wound healing by stimulating the proliferation and survival of human dermal fibroblasts through ERK and AKT pathwaysGrowth hormone-releasing hormone receptor splice variant 1 is frequently expressed in oral squamous cell carcinomas.
P2860
Q24292089-CE41DBFF-F758-4AA8-AA01-92DE7AEAB24FQ24309176-3803B6E7-F026-477B-9FBB-A2B03B4D7768Q30432613-74B36A56-827E-4C91-81D5-A00940046FCEQ30454262-AFA8CD1D-B733-4C5B-B33A-C8E65871B8A9Q33850519-65BB9AE1-7BEB-4184-A490-E8C54C6314A5Q33899059-D7FD7341-6BF2-40E7-945B-2E96C8199B18Q33906715-A53CC615-E3C9-4915-91AB-217C9E780200Q33927273-A8FD69A3-4DBB-434B-92A4-220ECB7E3250Q33933907-0F07A4B3-46F1-449A-A4C7-3D935F3C2AC2Q33939652-706CDEEA-5AE8-475A-9282-63F6CC8D4335Q34004827-641B4A4C-0A7C-4C22-9379-0D1CA4F96F95Q34154583-3169F17E-0C6A-4D69-8814-BD5FB84A604DQ34161110-F659D5E7-CE7C-4570-8648-AFE47BE1E5DCQ34330174-9BB53906-7ABC-45A5-B9E1-A9D3165D4A77Q34621536-F890719C-31B3-4B7B-96AF-73E51B9C31F8Q34781112-D91030F6-3C18-46E6-9A96-FB446295CD73Q34792237-627BEA62-3F11-4C4F-B049-F2C69A052F63Q34894406-EEA62761-0E16-4978-8A31-8B10A9C4F811Q35080727-3C3134FA-477E-4683-A489-D48988A010A9Q35185769-E7B6100D-5AB9-45CB-93A2-F087CEF68771Q35216414-E919A8E2-01E8-4CC5-B878-887598BEE0F7Q35629436-9060B319-7D10-4515-BEC1-A3DE6E895860Q35720666-95D21256-092E-4EB2-A79E-8176307D5BDCQ35749794-65BEF2CE-1F6A-4BFA-9845-B2C107AA053CQ35751094-2068E09A-C2C2-413B-A1D3-201739D4728CQ35882545-A2E97AD9-8171-4FBE-BA05-500F5DF799B8Q36161621-92191281-B733-4D7E-AD5E-DAB54D786415Q36696448-273BE2E6-D2EF-47D0-B17A-8EA953DD704BQ36748502-B7931FA6-8948-42F0-8694-EDC00C317B78Q36862773-ACE965E9-6502-4822-BB94-575333103F63Q37016373-CA6C6063-467E-4557-B026-D134607E6F55Q37068539-937625F9-FC01-4C4C-9BE5-308B2113BB73Q37080260-13029DC5-EFD2-4E52-813E-E186CD8F9570Q37278402-FC035F1C-6F37-4313-8FBB-59EB02ED6307Q37323454-CC3883D0-7944-4AC8-A113-E7CCE9B19EB1Q37519616-9B9F8DAD-968E-4211-AC92-CF01A9DB8BA2Q37589369-0CEA1F94-B0A3-40C4-94AF-4DBD223374DAQ37851157-809C191B-2FEA-4572-9C7E-96C5FDECACA1Q38834106-14CA0977-B27B-40E0-8B75-00F24ECC15E3Q39375139-8E6AE7A2-F045-4D20-9135-553FD3EE76A3
P2860
Isolation and sequencing of cDNAs for splice variants of growth hormone-releasing hormone receptors from human cancers.
description
2000 nî lūn-bûn
@nan
2000 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Isolation and sequencing of cD ...... e receptors from human cancers
@nl
Isolation and sequencing of cD ...... receptors from human cancers.
@ast
Isolation and sequencing of cD ...... receptors from human cancers.
@en
type
label
Isolation and sequencing of cD ...... e receptors from human cancers
@nl
Isolation and sequencing of cD ...... receptors from human cancers.
@ast
Isolation and sequencing of cD ...... receptors from human cancers.
@en
prefLabel
Isolation and sequencing of cD ...... e receptors from human cancers
@nl
Isolation and sequencing of cD ...... receptors from human cancers.
@ast
Isolation and sequencing of cD ...... receptors from human cancers.
@en
P2860
P3181
P356
P1476
Isolation and sequencing of cD ...... e receptors from human cancers
@en
P2093
P2860
P304
10561-10566
P3181
P356
10.1073/PNAS.180313297
P407
P577
2000-09-01T00:00:00Z